Apraglutide

Research use only, not for human use.

Apraglutide (FE 203799 is a synthetic 33-amino acid peptide and long-acting glp-2 analogue.

Apraglutide (FE 203799 is a synthetic 33-amino acid peptide and long-acting glp-2 analogue.(In Vivo):Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7.

——

Apraglutide (FE 203799; 5 mg/kg/dose, subcutaneously, twice on days 0 and 4 postsurgery) treated piglets are healthy, have significant lower fecal fat and energy losses and exhibite intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth on day 7. Animal Model:NewbornDuroc piglets, 2–5 days old and weighing between 2-2.6 kg.Dosage:5 mg/kg/dose.Administration:Subcutaneously, twice on days 0 and 4 postsurgery.Result:On day 7, treated piglets were healthy, had significant lower fecal fat and energy losses and exhibited intestinal lengthening, greater small-intestinal weight, longer villus height, and greater crypt depth.

FE 203799

GPCR/G Protein

Glucagon Receptor

——

——

——

1295353-98-8

3765.25

C172H263N43O52

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (26.56 mM)

——

Sequence:HGDGSFSDEX FTILDLLAAR DFINWLIQTK ITD-NH2

(-20℃)

With Ice Pack

≥ 2 years